Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

RNA Complete BCT – The Next Streck Tube

Products are for professional/laboratory use only.

Maintain draw time concentrations of cell-free RNA and extracellular vesicles with Streck RNA Complete BCT.

Extracellular vesicles, such as exosomes and microvesicles, are shed by all cells. Current stabilisation tubes, such as Streck’s Cell-Free DNA BCT®, effectively stabilise white blood cells and hence draw-time levels of cell-free DNA. They do not, however, maintain the integrity of all cells in the collected blood sample. In order to maintain draw-time EV concentrations, Streck designed a novel blood collection tube targeting erythrocytes and platelets in addition to white blood cells. In parallel with maintaining draw time levels of EVs, the vesicular contents of the EV population are also maintained. These contents, importantly, contain circulating RNA like mRNA

RNA Complete BCT is a direct draw blood collection tube that maintains the draw time concentration of cell-free RNA and extracellular vesicles, such as exosomes. The preservative stabilises cfRNA and exosome counts for up to seven days when stored at room temperature, maximising plasma yield and minimising haemolysis during storage. By limiting the degradation of white and red blood cells, the specialised chemistry provides sample integrity during storage, shipping, and handling of blood samples.

Streck RNA Complete BCT eliminates the need for immediate plasma preparation and  isolated cfRNA is suitable for downstream applications including ddPCR and next-generation sequencing.

 

Ordering Information:

Product Code

Description

ST230579

6-Tube Pack

ST230580

100-Tube Pack

ST230581

1000-Tube Pack


Discover Streck RNA Complete BCT™

View Technical Flyer >

Want to know more about Streck RNA Complete BCT™?

Request a Quote >



Request a Quote

Request Quote

Recent Posts

Asuragen – QuantideX ESR1 exoMutation Kit

ESR1 Mutations are the Leading Cause of Primary Treatment Resistance in HR+ mBC ESR1 gene codes for estrogen receptor alpha (ERα), and mutations in its ligand-binding domain…

Read full article

Biocartis – Idylla POLE-POLD1 Mutation Assay

The Idylla™ POLE-POLD1 Mutation Assay (RUO)* provides a rapid and reliable solution to close an important gap in oncology research by enabling molecular classification of…

Read full article

Biocartis – Idylla ThyroidPrint Assay

Idylla™ ThyroidPrint® Assay (RUO)* is a novel RT qPCR-based molecular signature that assesses a gene expression profile. Using a proprietary algorithm, ThyroidPrint provides assessment of…

Read full article